Jeanne Donohoe’s Post

How is AI shaping the future of drug development? Tom O’Leary, ICON’s Chief Information Officer, discusses with The Irish Times how AI is revolutionising the industry. From accelerating drug discovery to streamlining clinical trials, AI is optimising processes, enabling data-driven decisions, and delivering patient-centred innovations. ICON’s cutting-edge platforms, such as OneSearch and Cassandra, exemplify how technology is transforming site selection, patient recruitment, and regulatory planning. Click here to learn more in The Irish Times: https://ow.ly/M4N250UtXUw #ClinicalResearch #ArtificialIntelligence #InnovationInHealth

The global AI in clinical trials market is projected to surge from $𝟭.𝟰𝟮 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝟮𝟬𝟮𝟯 𝘁𝗼 𝗮 𝘄𝗵𝗼𝗽𝗽𝗶𝗻𝗴 $𝟴.𝟱 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟱, according to Roots Analysis (at a CAGR of 16%)! This rapid growth signifies the transformative power of AI in streamlining clinical trials. Clinion is at the forefront of this innovation, offering an AI-enabled, integrated eClinical platform that streamlines complex trials, accelerates development timelines, and fosters better data quality. Join us in shaping the future of clinical trials! Visit Clinion to learn more about our AI-powered solutions https://www.clinion.com/ #AIinclinicaltrials #Artificialintelligence #Clinicaltrials #Clinicalresearch #marketreport #FutureofAI #Innovation #Acceleration #eClinical #rootanalysis #AIininnovation

Exciting news for biopharma companies! 🚀 AI and data analytics are revolutionizing the landscape of drug repositioning. By harnessing the power of advanced algorithms and predictive analytics, we can sift through vast datasets to uncover hidden insights and identify novel drug repositioning opportunities. From pinpointing potential candidates to predicting efficacy and safety in clinical trials, AI offers a game-changing solution for drug repositioning. Additionally, AI provides a proactive and data-driven approach to post-marketing surveillance, enhancing patient safety and regulatory compliance.📊 Let's unlock new possibilities together and accelerate the journey towards life-changing treatments! 💊 #AI #healthcare #drugrepositioning

How will AI transform your day-to-day life? Christina Busmalis, our Chief Revenue Officer, sat down with Ipsen’s Head of Global Commercial L&D, Tim Batchelor, to discuss how technological advances are changing life sciences, healthcare and society. Thanks to James Turnbull and the Camino team for hosting this session. #LifeSciences #MedicalAffairs https://lnkd.in/dqNbBcAS

Transforming healthcare, one annotated image at a time! 🏥💡 Explore how image annotation is paving the way for groundbreaking advancements in diagnostics, virtual assistance, and drug development. #AI #ImageAnnotation #HealthcareInnovation #MachineLearning

AI holds tremendous potential for revolutionizing clinical development, yet operationalizing and scaling this technology presents its own set of challenges. Reuters Events and IBM have teamed up to provide a comprehensive guide on implementing a successful AI agenda in our new whitepaper. Learn about the five building blocks essential for integrating AI effectively into clinical development from top industry experts. Download now to gain valuable insights! https://bit.ly/49nIDRT #AIAgenda #Innovation #Pharma

Discover the transformative power of AI in pharma! Learn how it's streamlining care, speeding up diagnoses, and enhancing patient outcomes. Don't miss out—register now for our April 25 webinar: https://bit.ly/3xpfO8V #PharmaAI #Innovation

Discover the transformative power of AI in pharma! Learn how it's streamlining care, speeding up diagnoses, and enhancing patient outcomes. Don't miss out—register now for our April 25 webinar: https://bit.ly/3xpfO8V #PharmaAI #Innovation

With PV teams allocating 40 to 85% of budgets towards case processing, cutting-edge AI is transforming pharmacovigilance. From reducing case processing costs to slashing timelines, AI is rewriting the rules for efficiency and accuracy. In this week's Expert View, IQVIA’s Uwe Trinks examines the impact of new artificial intelligence-based tools on the pharma industry. Read more: https://bit.ly/4jatjN3 #AIInPharma #PharmaInnovation #AutomationInsights